{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Febrile neutropenia", "docetaxel", "non-small cell lung cancer"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "32643445", "DateCompleted": {"Year": "2020", "Month": "08", "Day": "24"}, "DateRevised": {"Year": "2020", "Month": "08", "Day": "24"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "07", "Day": "30"}], "ELocationID": ["10.1080/07357907.2020.1793350"], "Journal": {"ISSN": "1532-4192", "JournalIssue": {"Volume": "38", "Issue": "7", "PubDate": {"Year": "2020", "Month": "Aug"}}, "Title": "Cancer investigation", "ISOAbbreviation": "Cancer Invest"}, "ArticleTitle": "Primary Prophylaxis Indication for Docetaxel Induced Febrile Neutropenia in Elderly Patients with Non-Small Cell Lung Cancer.", "Pagination": {"StartPage": "424", "EndPage": "430", "MedlinePgn": "424-430"}, "Abstract": {"AbstractText": ["In advanced non-small cell lung cancer (NSCLC), the reported incidence of febrile neutropenia (FN) caused by docetaxel (DTX) is 10-20% in clinical trial data. However, FN incidence caused by DTX in real-world setting remains unclear. We evaluated FN incidence caused by DTX and identify risk factors of FN in real-world setting. One hundred and seventy-one NSCLC patients treated with DTX were retrospectively analyzed and 44 (26%) developed FN. Multivariate analysis identified higher age (\u226565\u2009years) and prior history of FN as independent risk factors for FN. Primary prophylaxis for FN might be recommended in elderly patients with/without prior history of FN."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan."}], "LastName": "Matsui", "ForeName": "Akira", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan."}], "LastName": "Morise", "ForeName": "Masahiro", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan."}], "LastName": "Tanaka", "ForeName": "Ichidai", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan."}], "LastName": "Ozone", "ForeName": "Sachiko", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan."}], "LastName": "Matsuzawa", "ForeName": "Reiko", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan."}], "LastName": "Koyama", "ForeName": "Junji", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan."}], "LastName": "Hase", "ForeName": "Tetsunari", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan."}], "LastName": "Hashimoto", "ForeName": "Naozumi", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan."}], "LastName": "Sato", "ForeName": "Mitsuo", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Hospital Organization Nagoya Medical Center, Nagoya, Japan."}], "LastName": "Hasegawa", "ForeName": "Yoshinori", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Cancer Invest", "NlmUniqueID": "8307154", "ISSNLinking": "0735-7907"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "15H5577CQD", "NameOfSubstance": "Docetaxel"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Aged, 80 and over"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Carcinoma, Non-Small-Cell Lung"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Docetaxel"}, {"QualifierName": ["chemically induced", "prevention & control"], "DescriptorName": "Febrile Neutropenia"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Lung Neoplasms"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Multivariate Analysis"}, {"QualifierName": [], "DescriptorName": "Retrospective Studies"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2020", "Month": "7", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "10", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32643445", "10.1080/07357907.2020.1793350"]}}], "PubmedBookArticle": []}